Mozart Therapeutics

Developer of therapeutics for treating inflammatory and autoimmune diseases

placeSeattle, Washington, United States calendar_todayFounded 2020 groups14 employees language mozart-tx.com

Registered entities

Innovation

5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 972 times.

YearFilings
20221
20232
20243
20253
20261

Social engagement

Social engagement: 3.5K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Arch Venture Partners, Sofinnova Partners.

Investor typeCountShare
Venture capital650%
Other / undisclosed650%
Coming soon